CTNM
Contineum Therapeutics Inc.
$11.63
-$1.44(-11.02%)
54
Overall
60
Value
63
Tech
39
Quality
Market Cap
$340.56M
Volume
1.50M
52W Range
$3.35 - $15.25
Target Price
$22.00
EPS Estimates Overview
| Current Quarter | $-0.53 | Next Quarter | $-0.63 |
| Current Year | $-2.21 | Next Year | $-2.25 |
| QoQ Growth | -18.9% | YoY Growth | -1.8% |
| 3Y EPS CAGR | N/A | Target Price | $22.00 |
| Consensus | Buy | Upside | +89.2% |
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CTNM | $11.63 | -11.0% | 1.50M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Contineum Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW